Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

by Global Biodefense Staff December 19, 2020, 2:02 pm
Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

by JoNel Aleccia, Kaiser Health News December 14, 2020, 5:33 pm
How COVID-19 Vaccines Will Get From the Factory to Your Community

by Bahar Aliakbarian December 4, 2020, 9:25 am
Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

by Matthew Woodruff December 3, 2020, 10:52 am
CONVINCE USA Aims to Address Public Concerns About COVID-19 Vaccine

by Global Biodefense Staff December 2, 2020, 4:13 pm
OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

by Global Biodefense Staff December 1, 2020, 3:07 pm
Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire

by Sanjay Mishra December 1, 2020, 9:33 am
Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

by Global Biodefense Staff November 25, 2020, 2:38 pm
COVID-19 Vaccines Were Developed in Record Time – But are These Game-Changers Safe?

by William Petri November 20, 2020, 1:07 pm
Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

by Global Biodefense Staff November 20, 2020, 8:37 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

by Global Biodefense Staff November 18, 2020, 3:18 pm
Until a Coronavirus Vaccine is Ready, Pneumonia Vaccines May Reduce Deaths from COVID-19

by Robert Root-Bernstein, Michigan State University October 15, 2020, 6:37 pm
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva

by Global Biodefense Staff October 15, 2020, 7:18 am
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation

by Global Biodefense Staff October 8, 2020, 7:01 am

Congratulations. You've reached the end of the internet.

Vaccines

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

Novel Inhaled Vaccine for Tuberculosis Shows Strong Immune Response in Mice

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

How COVID-19 Vaccines Will Get From the Factory to Your Community

Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

CONVINCE USA Aims to Address Public Concerns About COVID-19 Vaccine

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

COVID-19 Vaccines Were Developed in Record Time – But are These Game-Changers Safe?

Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

Until a Coronavirus Vaccine is Ready, Pneumonia Vaccines May Reduce Deaths from COVID-19

U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva

Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles